Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$149,438
+$6,697 QoQ
Shares Held
1,606
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#195
of 282 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestcor Inc holds $65,816,304 across 34 Biotechnology names. BNTX ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,242 | $13,531,918 | |
| 2 | INCY |
Incyte Corp
|
114,821 | $13,016,108 | |
| 3 | EXEL |
Exelixis, Inc.
|
132,700 | $7,220,207 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
50,000 | $6,636,500 | |
| 5 | TECH |
BIO-TECHNE Corp
|
90,000 | $6,358,500 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,959 | $2,640,790 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
119,319 | $2,024,843 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,060 | $1,824,241 |
All Filings in BNTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,438 | 1,606 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $142,741 | 1,606 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $152,796 | 1,605 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $1,128,105 | 9,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $783,882 | 6,600 | Shares | Sole | 2024-11-15 | |
| 2020-09-30 | $2,700,385 | 39,006 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||